Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash & Equivalents (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Cash & Equivalents for 9 consecutive years, with $9.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 194.63% to $9.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.6 million, a 194.63% increase, with the full-year FY2024 number at $10.2 million, up 469.67% from a year prior.
  • Cash & Equivalents was $9.6 million for Q3 2025 at SANUWAVE Health, up from $8.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $10.2 million in Q4 2024 to a low of $106000.0 in Q1 2023.
  • A 3-year average of $4.4 million and a median of $2.9 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 2669.81% in 2024, then soared 189.54% in 2025.
  • SANUWAVE Health's Cash & Equivalents stood at $1.8 million in 2023, then soared by 469.67% to $10.2 million in 2024, then fell by 6.2% to $9.6 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Cash & Equivalents are $9.6 million (Q3 2025), $8.5 million (Q2 2025), and $8.5 million (Q1 2025).